AtRMR1 functions as a cargo receptor for protein trafficking to the protein storage vacuole

Organellar proteins are sorted by cargo receptors on the way to their final destination. However, receptors for proteins that are destined for the protein storage vacuole (PSV) are largely unknown. In this study, we investigated the biological role that Arabidopsis thaliana receptor homology region transmembrane domain ring H2 motif protein (AtRMR) 1 plays in protein trafficking to the PSV. AtRMR1 mainly colocalized to the prevacuolar compartment of the PSV, but a minor portion also localized to the Golgi complex. The coexpression of AtRMR1 mutants that were localized to the Golgi complex strongly inhibited the trafficking of phaseolin to the PSV and caused accumulation of phaseolin in the Golgi complex or its secretion. Coimmunoprecipitation and in vitro binding assays revealed that the lumenal domain of AtRMR1 interacts with the COOH-terminal sorting signal of phaseolin at acidic pH. Furthermore, phaseolin colocalized with AtRMR1 on its way to the PSV. Based on these results, we propose that AtRMR1 functions as the sorting receptor of phaseolin for its trafficking to the PSV

Development of A New Coating System for The High Functional Mold in Thin-wall Casting

A new inorganic binder system has been developed to prepare the mold having a high strength for the thin-walled casting. To increase the fracture strength at high temperature, a large amount of inorganic binder should be converted into glass phase and the generated glass phase has to be homogeneously coated on the surface of starting particles. In this work, two types of process were employed to investigate the coating and glassification efficiencies of inorganic precursor. In the first process (process I), the green body consisting of starting powder and organic binder was dipped in the inorganic precursor solution. In the second process (process II), the starting powder was coated by inorganic precursor, and then the organic binder was used to form the green body. The mold sample prepared using process II showed the higher strength value than that using process I, owing to the inclement effect on the glassfication efficiency by the loss of inorganic precursor in process I. The prepared real mold was perfectly produced and the casted product showed a clean surface without defects such as dross, nonmetallic inclusions, and crack. Consequently, the new inorganic binder system could be applied for preparing the mold for the thin-wall casting having high mechanical properties

Thermoelastic Characteristics in Thermal Barrier Coatings with a Graded Layer between the Top and Bond Coats

A graded layer was introduced at the interface between the top and bond coats to reduce the risk of failure in a thermal barrier coating (TBC) system, and the thermoelastic behavior was investigated through mathematical approaches. Two types of TBC model with and without the graded layer, subject to a symmetric temperature distribution in the longitudinal direction, were taken into consideration to evaluate thermoelastic behaviors such as temperature distribution, displacement, and thermal stress. Thermoelastic theory was applied to derive two governing partial differential equations, and a finite volume method was developed to obtain approximations because of the complexity. The TBC with the graded layer shows improved durability in thermoelastic characteristics through mathematical approaches, in agreement with the experimental results. The results will be useful in discovering technologies for enhancing the thermomechanical properties of TBCs

Additive Manufacturing of Metallic Materials: A Review

In this review article, the latest developments of the four most common additive manufacturing methods for metallic materials are reviewed, including powder bed fusion, direct energy deposition, binder jetting, and sheet lamination. In addition to the process principles, the microstructures and mechanical properties of AM-fabricated parts are comprehensively compared and evaluated. Finally, several future research directions are suggested

Microstructure design for blended feedstock and its thermal durability in lanthanum zirconate based thermal barrier coatings

The effects of microstructure design on the lifetime performance of lanthanum zirconate (La2Zr2O7; LZO)-based thermal barrier coatings (TBCs) were investigated through various thermal exposure tests, such as furnace cyclic thermal fatigue, thermal shock, and jet engine thermal shock. To improve the thermal durability of LZO-based TBCs, composite top coats using two feedstock powders of LZO and 8 wt.% yttria-doped stabilized zirconia (8YSZ) were prepared by mixing in different volume ratios (50:50 and 25:75, respectively). In addition, buffer layers were introduced in layered LZO-based TBCs deposited using an air-plasma spray method. The TBC with the double buffer layer showed the best thermal cycle performance among all samples in all tests. For applications with relatively slow cooling rates, the thermal durability in single-layer TBCs is more effectively enhanced by controlling a composition ratio in the blended powder, better than introducing a single buffer layer. For applications with relatively fast cooling rates, the thermal durability can be effectively improved by introducing a buffer layer than controlling a composition in the top coat, since the buffer layer provides fast localized stress relief due to its high strain compliance. These research findings allow us to control the TBC structure, and the buffer layer is efficient in improving thermal durability in cyclic thermal environments

Randomized Comparison of Four-Times-Daily versus Once-Daily Intravenous Busulfan in Conditioning Therapy for Hematopoietic Cell Transplantation

AbstractSixty patients were randomized to receive intravenous busulfan (iBU) either as 0.8 mg/kg, over 2 hours 4 times a day (BU4 arm) or 3.2 mg/kg, over 3 hours once a day (BU1 arm) in conditioning therapy for hematopoietic cell transplantation. The complete pharmacokinetic parameters for the first busulfan dose were obtained from all patients and were comparable between the 2 arms: for the BU4 and BU1 groups, elimination half-life (mean ± SD) was 2.75 ± 0.22 versus 2.83 ± 0.21 hours, estimated daily AUC was 6058.0 ± 1091.9 versus 6475.5 ± 1099.4 μM·min per day, and clearance was 2.05 ± 0.36 versus 1.91 ± 0.31 mL/min/kg, respectively. Times to engraftment after transplantation were similar between the 2 arms. No significant differences were evident in the occurrence of acute graft-versus-host disease (aGVHD) and hepatic veno-occlusion disease (VOD). Moreover, other toxicities observed within 100 days after transplantation were not significantly different between the 2 arms. The cumulative incidence of nonrelapse mortality was 20.8% in BU4 arm and 13.3% in BU1 arm. In conclusion, our randomized study demonstrates that the pharmacokinetic profiles and posttransplant complications are similar for once-daily iBU and traditional 4-times-daily iBU

Characterization of Microstructure and Mechanical Properties of Direct Metal Laser Sintered 15–5 PH1 Stainless Steel Powders and Components

15–5 PH1 stainless steel powder is one of the common materials used for the DMLS process. In this study, both the powder and parts fabricated via DMLS have been characterized. The microstructure and elemental composition have been examined. The microhardness and surface roughness have also been measured. The results show that most powder particle are in spherical with a particle size of 5 ~ 60 μm. Chemical compositions of the powder compare well with the literature data. The thickness of rough surface is about 1 μm. The measured Rockwell hardness is HRC 42.9±0.3, which is also in good agreement with literature

Nonleukemic Granulocytic Sarcoma in the Bile Duct: A Case Report

Granulocytic sarcoma (GS) is an extramedullary tumor composed of immature myeloid cells, typically occurring during the course of acute myelogenous leukemia. Nonleukemic GS, that is, GS with no evidence of overt leukemia and no previous history of leukemia, is very rare, and even more unusual is nonleukemic GS of the bile duct. We report a case of nonleukemic GS of the bile duct. The patient was initially misdiagnosed as a bile duct carcinoma arising in the hilum of the liver (so-called Klatskin tumor), and received a right lobectomy of the liver. Histological examination of the tumor yielded the diagnosis of GS, and the bone marrow biopsy did not show any evidence of leukemia. Considering the risk of subsequent development of overt leukemia, the patient was treated with two cycles of combination chemotherapy as used in the cases of acute myelogenous leukemia. To date, he has remained free of disease 15 months after treatment

Alleviating psoriatic skin inflammation through augmentation of Treg cells via CTLA-4 signaling peptide

Psoriasis is a chronic inflammatory skin disease characterized by hyperplasia of keratinocytes and immune cell infiltration. The IL-17-producing T cells play a key role in psoriasis pathogenesis, while regulatory T (Treg) cells are diminished during psoriatic inflammation. Current psoriasis treatments largely focus on IL-17 and IL-23, however, few studies have explored therapeutic drugs targeting an increase of Treg cells to control immune homeostasis. In this study, we investigated the effects of a cytotoxic T lymphocyte antigen-4 (CTLA-4) signaling peptide (dNP2-ctCTLA-4) in Th17, Tc17, γδ T cells, Treg cells in vitro and a mouse model of psoriasis. Treatment with dNP2-ctCTLA-4 peptide showed a significant reduction of psoriatic skin inflammation with increased Treg cell proportion and reduced IL-17 production by T cells, indicating a potential role in modulating psoriatic skin disease. We compared dNP2-ctCTLA-4 with CTLA-4-Ig and found that only dNP2-ctCTLA-4 ameliorated the psoriasis progression, with increased Treg cells and inhibited IL-17 production from γδ T cells. In vitro experiments using a T cell-antigen presenting cell co-culture system demonstrated the distinct mechanisms of dNP2-ctCTLA-4 compared to CTLA-4-Ig in the induction of Treg cells. These findings highlight the therapeutic potential of dNP2-ctCTLA-4 peptide in psoriasis by augmenting Treg/Teff ratio, offering a new approach to modulating the disease